Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Boston, MA
SEC filing record 1 source field available
Fiscal year end
31 December
RHYTHM PHARMACEUTICALS, INC. has filed 806 SEC EDGAR filings since 12 Aug 2015

SEC filing history

Showing 701-725 of 806 matching filings.

Per page
25
Current page
29
SC 13D/A File 005-90134

AMENDMENT NO. 2

Filing date
04 Jun 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
24 May 2018
Reporting date
22 May 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
21 May 2018
Reporting date
18 May 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-38223

8-K

Filing date
14 May 2018
Reporting date
14 May 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
10 May 2018
Reporting date
09 May 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
DEF 14A File 001-38223

DEF 14A

Filing date
30 Apr 2018
Reporting date
06 Jun 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-38223

8-K

Filing date
02 Apr 2018
Reporting date
02 Apr 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-38223

8-K

Filing date
14 Mar 2018
Reporting date
12 Mar 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
S-8 File 333-223647

S-8

Filing date
14 Mar 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
16 Feb 2018
Reporting date
14 Feb 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
16 Feb 2018
Reporting date
14 Feb 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
16 Feb 2018
Reporting date
14 Feb 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
16 Feb 2018
Reporting date
14 Feb 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
16 Feb 2018
Reporting date
14 Feb 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-90134

SCHEDULE 13G

Filing date
13 Feb 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-90134

SC 13G

Filing date
13 Feb 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A File 005-90134

AMENDMENT NO. 1

Filing date
07 Feb 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-38223

8-K

Filing date
01 Nov 2017
Reporting date
31 Oct 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D File 005-90134

SC 13D

Filing date
24 Oct 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D File 005-90134

SCHEDULE 13D

Filing date
20 Oct 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-90134

SCHEDULE 13G

Filing date
18 Oct 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D File 005-90134

NEW ENTERPRISE ASSOCIATES 13, L.P. - RHYTHM PHARMACEUTICALS, INC. 13D

Filing date
13 Oct 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .